Cercek, Andrea

Publications

Sort by

Co-Author Network

selected publications

A rectal cancer organoid platform to study individual responses to chemoradiation. Nature medicine. 2019 Academic Article GET IT
Times cited: 239
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2019 Academic Article GET IT
Times cited: 7
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA oncology. 2019 Academic Article GET IT
Times cited: 270
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 21
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 276
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. Journal of the American College of Surgeons. 2017 Academic Article GET IT
Times cited: 44
Robotic hepatic arterial infusion pump placement. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2017 Academic Article GET IT
Times cited: 19
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cellular and molecular gastroenterology and hepatology. 2017 Review GET IT
Times cited: 171
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2016 Academic Article GET IT
Times cited: 36
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. Journal of surgical oncology. 2016 Academic Article GET IT
Times cited: 38
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min. Journal of oncology practice. 2016 Academic Article GET IT
Times cited: 4
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 175
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. Journal of surgical oncology. 2016 Academic Article GET IT
Times cited: 60
Erratum to: Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review. Annals of surgical oncology. 2015 Article GET IT
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors. Investigational new drugs. 2015 Academic Article GET IT
Times cited: 31
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015 Academic Article GET IT
Times cited: 3
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Annals of surgery. 2015 Academic Article GET IT
Times cited: 140
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 213
Treatment of peritoneal carcinomatosis of colorectal origin. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2015 Review GET IT
Times cited: 5
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer. Clinical colorectal cancer. 2014 Academic Article GET IT
Times cited: 30
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome biology. 2014 Academic Article GET IT
Times cited: 259
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 70
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014 Academic Article GET IT
Times cited: 146
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 149
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 336
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 23
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 32
Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management. Current treatment options in oncology. 2013 Review GET IT
Times cited: 17
Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 24
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Annals of surgical oncology. 2013 Academic Article GET IT
Times cited: 37
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease. Journal of surgical oncology. 2012 Academic Article GET IT
Times cited: 11
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012 Academic Article GET IT
Times cited: 1433
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 225
Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patients. Current treatment options in oncology. 2011 Academic Article GET IT
Times cited: 2
Evolving treatment of advanced colorectal cancer. Current oncology reports. 2010 Review GET IT
Times cited: 16
First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents. Clinical colorectal cancer. 2008 Review GET IT
Times cited: 7
Involvement of the helix-loop-helix protein Id-1 in the glucocorticoid regulation of tight junctions in mammary epithelial cells. The Journal of biological chemistry. 2000 Academic Article GET IT
Times cited: 30

more ...

less ...

Background

education and training

M.D., New York Medical College 2004
B.A., University of California 1999

Contact

full name

Andrea Cercek

VIVO Weill Cornell Medical College

Andrea Cercek Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name